Erratum to current state of immunotherapy for non-small cell lung cancer

Схожие документы

• Current state of immunotherapy for non-small cell lung cancer
  по: Malhotra, Jyoti, et al.
  Опубликовано: (2017)
• Local treatment of synchronous oligometastatic non-small cell lung cancer (NSCLC)—current consensus and future perspectives
  по: Almeldin, Doaa Said, et al.
  Опубликовано: (2020)
• Patient-related outcomes with the use of checkpoint inhibitors for the treatment of metastatic non-small cell lung cancer
  по: Malhotra, Jyoti, et al.
  Опубликовано: (2018)
• Impact of surveillance frequency on survival in non-small cell lung cancer (NSCLC) survivors
  по: Malhotra, Jyoti, et al.
  Опубликовано: (2019)
• Prognostic Impact of Missed Chemotherapy Doses During Chemoradiation Therapy for Non–Small Cell Lung Cancer
  по: Deek, Matthew P., et al.
  Опубликовано: (2018)